Dec 18, 2020 / NTS GMT
Hiroshi Nomura - Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director
My Name is Hiroshi Nomura. I'm the President and CEO of Sumitomo Dainippon Pharma. Thank you for joining ESG meeting today. Thank you also for having interest in our company. Your feedback, comments and opinions are very important in managing the company. So I'm looking forward to the discussions today with you.
I would like to explain business model, materiality and corporate governance. After my presentation, Kimura-san will present R&D part, and Higuchi-san will present human resources, social contributions and environment.
This is my first slide regarding business model. On the left, you see 6 types of capital, intellectual capital, social and relationship capital, human capital, financial capital and manufactured capital. We use those capital in our strength in R&D, global platform and human resources. Capitalizing on those strengths, Sumitomo focuses on materiality that creates value and materiality that forms foundation for business continuity. These are very important in our
Sumitomo Dainippon Pharma Co Ltd ESG Briefing Transcript
Dec 18, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers